FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:2115-2117 November 11, 2004 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by The PEACE Trial Investigators PubMed Citation

Angiotensin-converting–enzyme (ACE) inhibitors are effective in reducing mortality and morbidity from cardiovascular events among patients who have chronic heart failure due to left ventricular systolic dysfunction and in those who have acute myocardial infarction with or without left ventricular systolic dysfunction. ACE inhibitors are also effective in reducing mortality and morbidity from cardiovascular events in high-risk patients with diabetes mellitus as well as those with renal dysfunction. In addition, ACE inhibitors are effective antihypertensive agents, although current data suggest that they are not more effective in reducing mortality and morbidity from cardiovascular events than other classes of antihypertensive agents with . . . [Full Text of this Article]

Source Information

From the University of Michigan School of Medicine, Ann Arbor.

This article has been cited by other articles:

• Ong, H. T. (2009). Are Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Especially Useful for Cardiovascular Protection?. J Am Board Fam Med 22: 686-697 [Abstract] [Full Text]  
• Flammer, A. J., Sudano, I., Hermann, F., Gay, S., Forster, A., Neidhart, M., Kunzler, P., Enseleit, F., Periat, D., Hermann, M., Nussberger, J., Luscher, T. F., Corti, R., Noll, G., Ruschitzka, F. (2008). Angiotensin-Converting Enzyme Inhibition Improves Vascular Function in Rheumatoid Arthritis. Circulation 117: 2262-2269 [Abstract] [Full Text]  
• Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E. Jr, Chavey, W. E. II, Fesmire, F. M., Hochman, J. S., Levin, T. N., Lincoff, A. M., Peterson, E. D., Theroux, P., Wenger, N. K., Wright, R. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2007). ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50: e1-e157 [Full Text]  
• Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E. Jr, Chavey, W. E. II, Fesmire, F. M., Hochman, J. S., Levin, T. N., Lincoff, A. M., Peterson, E. D., Theroux, P., Wenger, N. K., Wright, R. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2007). ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50: 652-726 [Full Text]  
• Timmis, A. D, Feder, G., Hemingway, H. (2007). Prognosis of stable angina pectoris: why we need larger population studies with higher endpoint resolution. Heart 93: 786-791 [Abstract] [Full Text]  
• Sekhri, N, Feder, G S, Junghans, C, Hemingway, H, Timmis, A D (2007). How effective are rapid access chest pain clinics? Prognosis of incident angina and non-cardiac chest pain in 8762 consecutive patients. Heart 93: 458-463 [Abstract] [Full Text]  
• Pfeffer, M. A., Frohlich, E. D. (2006). Improvements in clinical outcomes with the use of angiotensin-converting enzyme inhibitors: cross-fertilization between clinical and basic investigation. Am. J. Physiol. Heart Circ. Physiol. 291: H2021-H2025 [Abstract] [Full Text]  
• Al-Mallah, M. H., Tleyjeh, I. M., Abdel-Latif, A. A., Weaver, W. D. (2006). Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Coll Cardiol 47: 1576-1583 [Abstract] [Full Text]  
• Deckers, J. W., Goedhart, D. M., Boersma, E., Briggs, A., Bertrand, M., Ferrari, R., Remme, W. J., Fox, K., Simoons, M. L., on behalf of the EUROPA Investigators, (2006). Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk. Eur Heart J 27: 796-801 [Abstract] [Full Text]  
• Jochmann, N., Stangl, K., Garbe, E., Baumann, G., Stangl, V. (2005). Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases. Eur Heart J 26: 1585-1595 [Abstract] [Full Text]  
• Williams, B. (2005). Recent hypertension trials: Implications and controversies. J Am Coll Cardiol 45: 813-827 [Abstract] [Full Text]  
• Yusuf, S., Pogue, J., Myers, M. G., McCullough, C., Pfeffer, M. A., Domanski, M. J., Braunwald, E. (2005). ACE Inhibition in Stable Coronary Artery Disease. NEJM 352: 937-939 [Full Text]  
• Gluckman, T. J., Sachdev, M., Schulman, S. P., Blumenthal, R. S. (2005). A Simplified Approach to the Management of Non-ST-Segment Elevation Acute Coronary Syndromes. JAMA 293: 349-357 [Abstract] [Full Text]  
• (2004). ACE Inhibition Challenged for Stable CAD with Preserved LV Function. Journal Watch Cardiology 2004: 3-3 [Full Text]  
• de Kam, P. J, Voors, A. A, Fici, F., van Veldhuisen, D. J, van Gilst, W. H (2004). Review: The revised role of ACE-inhibition after myocardial infarction in the thrombolytic/primary PCI era. Journal of Renin-Angiotensin-Aldosterone System 5: 161-168 [Abstract]  
• (2004). New Trial of ACE Inhibition in Stable Coronary Disease. JWatch General 2004: 1-1 [Full Text]